Rana Smalling, PhD

Rana Smalling, PhD has a diverse background in various scientific roles. Their most recent position was as a Field Application Scientist at Golden Helix, Inc., where they performed clinical variant evaluation, trained professionals in genomics, and wrote scientific articles and blog posts on clinical NGS analysis. Prior to that, they worked as a Senior Scientist at Montana Molecular, LLC, focusing on drug discovery and biosensors. They also served as a Biomedical Scientist at Vanderbilt University Medical Center, conducting research in oncology and pancreatic cancer. Before that, at the University of Utah, they obtained a PhD in Biochemistry, with a focus on metabolism and liver cancer research. Their work included identifying gene signatures in liver disease progression and investigating the role of the RBP4 vitamin A signaling pathway. They began their research career as a Research Technician at the University of Chicago, where they contributed to studies on colorectal and breast cancer, including identifying genetic factors in racial survival disparity in colorectal cancer and investigating the significance of BRCA1 promoter methylation in breast cancer.

Rana Smalling, PhD, completed their Bachelor's degree in Biological Sciences at the University of Chicago from 2006 to 2010. Rana then pursued higher education at the University of Utah, where they obtained their Doctor of Philosophy (PhD) in Biochemistry between 2011 and 2018.